Related Experiment Video
Updated: Dec 21, 2025

Author Spotlight: Insights and Innovations in Gene Expression Manipulation Techniques for Choroid Plexus Research
Published on: June 16, 2023
Per2 attenuates LPS-induced chondrocyte injury through the PTEN/PI3K/Akt signalling pathway
Yu Zhao1, Ding Ma1, Bingchen Dong1
1Depatment of Orthopaedics, Xi'an Ninth Hospital, Xi'an 710054, Shaanxi Province, PR China.
Abstract:
This research aimed to explore the role of period circadian clock 2 (Per2) in the evolution of osteoarthritis (OA) and the relevant mechanisms. Per2 messenger RNA (mRNA) and protein levels were markedly reduced in NHAC-kn cells treated with 5 µg/ml lipopolysaccharide (LPS) for 12 h. Then, pcDNA3.1-Per2 and si-Per2 were recruited to boost and reduce the expression of Per2, respectively. MTT assay, apoptosis analysis and enzyme-linked immunosorbent assay (ELISA) results showed that Per2 increased cell proliferation, while inhibited apoptosis and inflammation. Furthermore, the PTEN/PI3K/Akt signalling pathway was activated by Per2 overexpression; the CO-IP data confirmed that Per2 specifically bound to PTEN. Through employing IGF-1, a PI3K activator, we determined that Per2-mediated inflammation response in LPS-stimulated NHAC-kn cells through the PTEN/PI3K/Akt signalling pathway. In summary, the present study indicates that Per2 may serve as a novel therapeutic target through activating the PTEN/PI3K/Akt signalling pathway.
Insights
Period circadian clock 2 (Per2) plays a key role in osteoarthritis (OA) by promoting cell proliferation and inhibiting apoptosis and inflammation. Per2 activates the PTEN/PI3K/Akt pathway, suggesting it as a therapeutic target for OA.
Area of Science:
- Molecular Biology
- Chronobiology
- Osteoarthritis Research
Background:
- Osteoarthritis (OA) is a degenerative joint disease with complex mechanisms.
- The role of circadian clock genes, such as period circadian clock 2 (Per2), in OA pathogenesis is not fully understood.
Purpose of the Study:
- To investigate the function of Per2 in osteoarthritis.
- To elucidate the molecular mechanisms underlying Per2's role in OA, particularly its interaction with the PTEN/PI3K/Akt signaling pathway.
Main Methods:
- Reduced Per2 expression in human chondrocytes (NHAC-kn) using lipopolysaccharide (LPS).
- Manipulated Per2 levels using pcDNA3.1-Per2 (overexpression) and si-Per2 (knockdown).
- Assessed cell proliferation (MTT assay), apoptosis, inflammation (ELISA), and protein interactions (CO-IP).
- Investigated the PTEN/PI3K/Akt pathway activation using IGF-1.
Main Results:
- LPS treatment decreased Per2 mRNA and protein levels in NHAC-kn cells.
- Per2 overexpression enhanced cell proliferation, inhibited apoptosis, and reduced inflammation.
- Per2 specifically bound to PTEN, activating the PTEN/PI3K/Akt signaling pathway.
- Per2's anti-inflammatory effects in LPS-stimulated cells were mediated via this pathway.
Conclusions:
- Per2 plays a protective role in osteoarthritis by promoting chondrocyte proliferation and suppressing apoptosis and inflammation.
- Per2 exerts its effects by activating the PTEN/PI3K/Akt signaling pathway.
- Per2 represents a potential novel therapeutic target for osteoarthritis treatment.
Related Concept Videos
The JAK-STAT Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation

